Sharemaestro Newsreel

Canopy Growth (NASDAQ:CGC) Announces Quarterly Earnings Results

Canopy Growth (NASDAQ:CGC) reported stronger-than-expected quarterly earnings, with revenue up 13% year-over-year to C$81.2 million and a narrowed loss of C$0.02 per share, surpassing analyst estimates. The company showed improved adjusted gross margins and a reduced adjusted EBITDA loss, targeting positive adjusted EBITDA in …

Amphastar Pharmaceuticals, Inc. SEC Filing (Aug 7, 2026)

This article reports on Amphastar Pharmaceuticals, Inc.'s SEC Form 144 filing from August 7, 2026. The filing indicates a proposed sale of securities, detailing the class of securities, the broker involved (UBS Financial Services, Inc.), the number of shares, aggregate market value, and the …

Healthcare giant slashes key consultation fee to beat rivals

CVS Health (CVS) is targeting the earliest point in a customer's weight-loss drug decision: the first consultation. On Aug. 5, the company dropped the cash price of a MinuteClinic online weight-loss visit to $29, with no membership and no monthly fee. That is the …

Earnings Surge And Reaffirmed 2026 Outlook Might Change The Case For Investing In ANI Pharmaceuticals (ANIP)

Emergent BioSolutions (EBS) Stock Sinks As NARCAN Impairment Deepens Losses

Emergent BioSolutions (EBS) saw its stock drop 8.9% after reporting a Q2 net loss of US$180.2 million, primarily due to a significant non-cash impairment related to NARCAN. While its Medical Countermeasures business showed strong revenue growth and adjusted EBITDA, concerns were raised about balance …

Trulieve Cannabis (NYSE:TRLV) Releases Earnings Results, Beats Estimates By $0.05 EPS

ANI Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $109.12, Implies 32% Upside

Analysts have revised their average 12-month price target for ANI Pharmaceuticals, Inc. (ANIP) stock down slightly from $110 to $109.12, with a range of $91 to $124. This new target suggests a potential upside of approximately 32% from its August 6th closing price. The …

Aytu Biopharma Inc (AYTU) Stock News Today

This article from TradingKey provides a stock overview for Aytu Biopharma Inc (AYTU), displaying its current stock price, market cap, and a note indicating that more news, earnings, and analyst ratings are coming soon. It also lists various financial and analytical tools available on …

Anika Therapeutics (NASDAQ:ANIK) Raised to Strong-Buy at Zacks Research

Zacks Research has upgraded Anika Therapeutics (NASDAQ:ANIK) to a "strong-buy" rating. This upgrade follows the company's strong quarterly earnings, where EPS of $0.42 significantly beat the $0.03 consensus, and revenue of $32.61 million also exceeded expectations. Institutional investors hold a substantial portion of the …

Pacer Advisors Inc. Purchases Shares of 416,191 Emergent Biosolutions Inc. $EBS

Pacer Advisors Inc. recently acquired 416,191 shares of Emergent BioSolutions (NYSE:EBS) worth approximately $3.45 million, bringing its stake to 0.81%. This purchase comes despite Emergent BioSolutions reporting a strong Q2 earnings beat, as the stock subsequently fell 29.6% due to management cutting full-year and …

Lantheus (NASDAQ:LNTH) Releases Earnings Results, Beats Expectations By $0.25 EPS

InterCure Ltd (INCR) Earnings Forecast: Future EPS & Revenue Growth Estimates

SIGA Technologies Inc (SIGA) Stock News Today

Takeda (TAK) Q1 2026 Earnings Call Transcript

Amphastar Pharmaceuticals (AMPH) Stock Rebound Meets Margin Pressure And Valuation Gap

Bausch Health (BHC) Q2 2026 Earnings Call Transcript

Anika (ANIK) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, July 29, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Stephen D. GriffinSenior Vice President, Chief Accounting Officer, and Treasurer - Ian W. McLeodExecutive Director, Corporate Development and Investor Relations - Matthew …

Organogenesis (ORGO) Stock Price Sinks On Deeper Losses And Margin Crunch

Canopy Growth (Nasdaq: CGC) lifts Q1 sales 13%, cuts loss 68%

Canopy Growth Corporation reported a 13% increase in Q1 FY2027 net revenue to $81.165 million, driven by strong growth in both cannabis and Storz & Bickel segments. The company significantly narrowed its net loss by 68% to $14.579 million and improved Adjusted EBITDA loss …

Ironwood Pharmaceuticals (IRWD) Stock Faces A Sentiment Check After Raised Guidance

Talphera Inc (TLPH) Stock News Today

This article from TradingKey provides current stock information for Talphera Inc (TLPH), including its market cap and recent trading activity. It states that more news, earnings, and analyst ratings will be updated soon, indicating it is a placeholder for future developments. The article encourages …

Canopy Growth Corp SEC Filing (Aug 7, 2026)

This article reports on an SEC filing (Form ARS) by Canopy Growth Corp (CGC) on August 7, 2026. The filing had a low impact and neutral sentiment, according to AI-generated analysis. The article provides details on the filing, including its acceptance by SEC EDGAR …

Indivior PLC (INDV) Stock News Today

This page provides news and analysis for Indivior PLC (INDV) stock. It includes current stock price, market capitalization, P/E ratio, and states that more news will be available soon. The platform, TradingKey, offers general information and does not provide financial advice.

State Street Corporation (BCRX) discloses 15.2M BioCryst shares in 13G filing

State Street Corporation has disclosed a beneficial ownership of 15,191,098 shares of BioCryst Pharmaceuticals, Inc. common stock, which represents a 6% stake in the company. This disclosure was made via a Schedule 13G filing, indicating a passive investment. While State Street has shared dispositive …

Haleon plc (HLN) Stock Price, News, Quote & History

This page provides a comprehensive overview of Haleon plc (HLN) stock, including its current price, dividend information, key financial metrics, and performance data. It details the company's business in consumer healthcare, offering products like oral care, vitamins, and pain relief, and compares its performance …

Aytu Biopharma Inc (AYTU) Earnings Forecast: Future EPS & Revenue Growth Estimates

Aytu Biopharma Inc (AYTU) has an earnings forecast score of 8.00, ranking 58th in the Pharmaceuticals industry, with an average analyst price target of $8.00. Analysts largely recommend a "Buy" for AYTU, projecting future revenue of $12.28M and an EPS of -$0.33 for the …

ANI Pharmaceuticals 2026: Revenue $266.04M, EPS $1.05— 10-Q Summary

ANI Pharmaceuticals reported strong second-quarter 2026 results, with revenue reaching $266.04 million and diluted EPS at $1.05. This growth was primarily driven by significant volume gains in its Rare Disease segment, particularly Cortrophin Gel, and increased generics volume. The company also saw a substantial …

Xeris Biopharma (XERS) Stock Jumps On Record Revenue Despite Wider Losses

Neurocrine Biosciences, Inc. (NBIX) Stock Price, News, Quote & History

This Yahoo Finance page provides detailed stock information for Neurocrine Biosciences, Inc. (NBIX), including its current price, historical data, financial performance, analyst ratings, and company overview. It highlights key products like INGREZZA and several pipeline candidates for neurological and psychiatric disorders. The company's market …

Amphastar Pharmaceuticals, Inc. (AMPH) stock price, news, quote and history

This article provides a comprehensive overview of Amphastar Pharmaceuticals, Inc. (AMPH) stock, including its current price, historical data, financial performance, and analyst ratings. It details the company's product portfolio, which includes various injectable, inhalation, and intranasal products, and lists key financial metrics and comparisons …

ALVO: FDA Inspection Closure And Biosimilar Resubmissions Will Drive Upside

Alvotech (ALVO) has seen its fair value reset to $5.75 from $13.83 by analysts, reflecting updated assumptions on growth and profitability, despite recent positive regulatory developments. The FDA closed its inspection of Alvotech's Reykjavik facility with a Voluntary Action Indicated classification, and the company …

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive information on Amylyx Pharmaceuticals, Inc. (AMLX), including its current stock price, recent news, historical data, and financial performance. It details the company's focus on developing treatments for neurodegenerative and endocrine conditions, highlighting its pipeline of clinical-stage products. The …

Hims & Hers Health (HIMS) Launches AI Weight Loss Care, Is It Still A Bargain?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Hims & Hers Health (HIMS) just introduced an AI powered care experience for Hers weight loss members, including a connected smart scale and app …

Tilray Brands (NASDAQ:TLRY) Trading Up 2.9% - Should You Buy?

Tilray Brands (NASDAQ:TLRY) shares increased by 2.9% to $4.57 during mid-day trading, though volume was below average. The stock remains below its 200-day moving average, and while analyst sentiment is mixed, it leans towards a "Moderate Buy" with an $11.00 price target. The company …

United Therapeutics (UTHR) CEO sells 9,500 shares after option exercise

United Therapeutics Chairperson & CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 and subsequently sold these shares through a family trust in multiple transactions ranging from $512.50 to $532.3932 per share. These transactions, executed on August 6, 2026, were part …

Anika Therapeutics, Inc. (ANIK) Stock Price, News, Quote & History

This article provides comprehensive financial data for Anika Therapeutics, Inc. (ANIK), including its current stock price, historical performance, and key financial metrics. It details the company's orthopedic products and services, analyst ratings, and comparative data with other companies in the drug manufacturing industry. The …